Skip to main content

Translational research

With over 200 validated methods and models, a facilitated access to patient samples and a world class academic and industrial network, ERBC is uniquely positioned to establish the preclinical proof-of-concept of any therapies.

Thus, by performing in vitro functional assays and custom-designed assays and assessing the therapeutic effect of the test compound in relevant animal models, ERBC converts next-generation therapeutics into validated drug candidates across almost all therapeutic areas and indications (except infectious diseases).

In addition, the company also conducts exploratory programs that allow early detection of deleterious adverse effect and toxicity induced by New Chemical Entities.

Together, these translational studies contribute to clarify the mechanism of action of the drug candidate and obviously, to improve risk-taking and decision making.

GLP certified
our expertise by

Therapeutic areas

Cardiology

Neurology

Pneumology

Oncology

Immuno-oncology

Allergy

Dermatology

Gastro-enterology

Analgesia/inflammation

Endocrinology

Haematology

Nephrology

A comprehensive range of preclinical models for short and long-term toxicology studies

Our animal models

John joe

Mouse

John joe

Rat

John joe

Dog

John joe

Rabbit

John joe

Marmoset

John joe

Ferret

John joe

Cynomolgus Monkeys

John joe

Guinea Pig

John joe

Cat

John joe

Hamster

John joe

MiniPig

A wide range of services that span the entire drug discovery and development continuum and can be tailored to specific research conditions

Our Services

NEED TO CREATE YOUR

UNIQUE PROJECT

Each project is managed by a study director, relying on a multi-disciplinary team of experts.